• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT Back to Search Results
Model Number M00519221
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Perforation (2001)
Event Date 03/28/2022
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
Note: this report pertains to one of two devices used during the same procedure.It was reported to boston scientific corporation that an orise proknife and orise gel was used in the colon during an endoscopic submucosal dissection (esd) procedure performed on (b)(6) 2022.Near the end of the procedure, the patient coded.Code blue protocol was implemented and the patient was resuscitated.The patient was brought to surgery to repair a small perforation in the ascending colon, which was successfully treated with a clip.The patient decompensated over the next few days and died on (b)(6) 2022.The patient had multiple comorbidities and the family decided not to continue life support.No autopsy was performed, however the clinical cause of death was reported to be brain damage.The physician deemed the patient's death to be not related to the orise devices and probably related to the procedure.
 
Event Description
Note: this report pertains to one of two devices used during the same procedure.It was reported to boston scientific corporation that an orise proknife and orise gel was used in the colon during an endoscopic submucosal dissection (esd) procedure performed on (b)(6), 2022.Near the end of the procedure, the patient coded.Code blue protocol was implemented and the patient was resuscitated.The patient was brought to surgery to repair a small perforation in the ascending colon, which was successfully treated with a clip.The patient decompensated over the next few days and died on (b)(6), 2022.The patient had multiple comorbidities and the family decided not to continue life support.No autopsy was performed, however the clinical cause of death was reported to be brain damage.The physician deemed the patient's death to be not related to the orise devices and probably related to the procedure.***correction noted*** there was no surgery performed.The physician injected the site with orise gel to lift the lesion and an esd was performed using the orise proknife.A perforation was noted while closing the defect and a clip was successfully placed to treat the defect.The patient then coded, code blue protocol initiated, and patient was resuscitated.The patient decompensated over the next few days, family withdrew life support and the patient expired on (b)(6), 2022.Cause of death was reported to be brain damage.In the physician's assessment, there was no malfunction of the orise gel and orise proknife, nor did they cause or contribute to the patient's death, however the death was deemed probably related to the procedure.
 
Manufacturer Narrative
Block d4 and h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: conclusion code 4316 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: correction: b2, b5, h1, h6 have been corrected based on review from 13may2022.
 
Event Description
Note: this report pertains to one of two devices used during the same procedure.It was reported to boston scientific corporation that an orise proknife and orise gel was used in the colon during an endoscopic submucosal dissection (esd) procedure performed on (b)(6), 2022.Near the end of the procedure, the patient coded.Code blue protocol was implemented and the patient was resuscitated.The patient was brought to surgery to repair a small perforation in the ascending colon, which was successfully treated with a clip.The patient decompensated over the next few days and died on (b)(6), 2022.The patient had multiple comorbidities and the family decided not to continue life support.No autopsy was performed, however the clinical cause of death was reported to be brain damage.The physician deemed the patient's death to be not related to the orise devices and probably related to the procedure.Correction noted.There was no surgery performed.The physician injected the site with orise gel to lift the lesion and an esd was performed using the orise proknife.A perforation was noted while closing the defect and a clip was successfully placed to treat the defect.The patient then coded, code blue protocol initiated, and patient was resuscitated.The patient decompensated over the next few days, family withdrew life support and the patient expired on (b)(6), 2022.Cause of death was reported to be brain damage.In the physician's assessment, there was no malfunction of the orise gel and orise proknife, nor did they cause or contribute to the patient's death, however the death was deemed probably related to the procedure.
 
Manufacturer Narrative
Block d4 and h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: conclusion code d17 is being used in lieu of an adequate conclusion code for "device not returned." block h10: the complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: correction: event date b3 has been corrected based on the review that the orise device was not related to the patient's death.Event date has been updated as the same date of the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORISE GEL
Type of Device
SUBMUCOSAL INJECTION AGENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
business & technonlogy park
cork
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14256037
MDR Text Key290441395
Report Number3005099803-2022-02349
Device Sequence Number1
Product Code PLL
UDI-Device Identifier08714729993841
UDI-Public08714729993841
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K180068
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00519221
Device Catalogue Number2202-03
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/05/2022
Initial Date FDA Received04/29/2022
Supplement Dates Manufacturer Received05/13/2022
06/09/2022
Supplement Dates FDA Received06/02/2022
06/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death;
Patient Age77 YR
Patient SexMale
Patient Weight87 KG
Patient RaceWhite
-
-